The Influence of Oncogenic RAS on Chemotherapy and Radiotherapy Resistance Through DNA Repair Pathways

RAS oncogenes are chief tumorigenic drivers, and their mutation constitutes a universal predictor of poor outcome and treatment resistance. Despite more than 30 years of intensive research since the identification of the first RAS mutation, most attempts to therapeutically target RAS mutants have fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Cáceres-Gutiérrez, Rodrigo E., Alfaro-Mora, Yair, Andonegui, Marco A., Díaz-Chávez, José, Herrera, Luis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962660/
https://www.ncbi.nlm.nih.gov/pubmed/35359456
http://dx.doi.org/10.3389/fcell.2022.751367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962660/
https://www.ncbi.nlm.nih.gov/pubmed/35359456
http://dx.doi.org/10.3389/fcell.2022.751367

Ejemplares similares